SAN DIEGO — The sickle cell community has for the past few days been buzzing with news of the first-ever approved gene therapies for the devastating disease. Meanwhile, researchers at the American ...
In October of 2022, Peter Emigh, who’d recently transitioned out of his role leading geriatric care for an in-home services provider, had dinner with some folks at venture capital firm Red Cell ...